CCR2 and neuroblastoma: Flow cytometry was performed to measure surface expression of CCR2 (CD192), the native receptor for CCL2, on peripheral blood mononuclear cells obtained from 14 patients with neuroblastoma just prior to the initiation of systemic treatment (clinical trial NANT 2011-04, NCT01711554, provided by Dr. Araz Marachelian).